强生2024年财报出炉!达雷妥尤单抗116亿美元,传奇CAR-T同比增长92.7%

医药魔方
22 Jan

1月22日,强生公布了2024年业绩,全年总营收888.21亿美元,同比增长4.3%。强生旗下两大核心业务板块——创新制药和医疗科技,分别实现了569.64亿美元(+4.0%)以及318.57亿美元(+4.8%)的收入。强生的创新制药业务主要聚焦肿瘤、自身免疫、神经科学、感染、肺动脉高压、心血管及代谢这几大关键领域。其中,肿瘤和自免对业绩的贡献最为突出,前者在2024全年取得了207.81亿美元的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10